MSK in collaboration with University of Hawaii Cancer Center present APPLE's Single Topic Conference: Hepatocellular Carcinoma Tumor Immune Microenvironment

This Memorial Sloan Kettering Cancer Center (MSK) virtual conference is hosted in collaboration with the University of Hawaii Cancer Center (UHCC) and endorsed by the Asian Pacific Primary Liver Cancer Expert Association (APPLE). This is a single topic conference focused on the Hepatocellular Carcinoma Tumor Immune Microenvironment and the use of checkpoint inhibitors in combination with other therapies including anti-angiogenics, tyrosine kinase inhibitors, other checkpoint inhibitors, plus other local therapies. This conference is intended for medical oncologists, hepatologists, gastroenterologists, interventional radiologists, surgeons, radiation oncologists, immunologists, basic science experts, plus all colleagues with an interest in Hepatocellular Carcinoma and Immunotherapy.

MSK and UHCC are excited to host the first single topic conference albeit virtually, and honored to welcome APPLE on the other side of the Pacific!

DAY 1

New York: Friday, December 4 - 6:00-9:15 pm
Honolulu: Friday, December 4 - 1:00-4:15 pm
Beijing, Hong Kong, Singapore, & Taipei: Saturday, December 5 - 7:00-10:15 am
Seoul & Tokyo: Saturday, December 5 - 8:00-11:15 am

DAY 2

New York: Saturday, December 5 - 6:00-9:15 pm
Honolulu: Saturday, December 5 - 1:00-4:15 pm
Beijing, Hong Kong, Singapore, & Taipei: Sunday, December 6 - 7:00-10:15 am
Seoul & Tokyo: Sunday, December 6 - 8:00-11:15 am

VIEW THE PROGRAM BROCHURE AND AGENDA

This live virtual course will be delivered using Zoom. We encourage all attendees to download the Zoom app prior to the start of the course (zoom.us/download). CME credit and ABIM MOC points will be offered and a certificate will be available after a course evaluation is complete. Additional details will be emailed to attendees before the course. 

Watch highlights from the live conference as well as an overview of each presentation from Chih-Hung Hsu, MD, PhD on Vimeo.

1. Identify the elements of the tumor immune microenvironment
2. Learn the outcome data of the different checkpoint inhibitors combination therapies for hepatocellular carcinoma
3. Assess potential role of tumor immune microenvironment in response to therapy

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities. Visit our Help page for more information. 

Registration Discounts/Promotions

• MSK CME offers a discounted rate for MSK Alumni, MSK Cancer Alliance and Cancer Care Partners. If you are a member of one of these groups, please contact [email protected] for more information.
• MSK employee registration is complimentary. However, you must complete course registration in order to attend this course. If you are registered for this course and are unable to attend, please email [email protected].

Please note that after your payment has been processed, no further promotional discount adjustments will be made to your registration.

Cancellation Policy

If you cancel your participation in this course, your registration fee, less a $25 administrative fee, will be refunded when email notification is received by the MSK Office of Continuing Medical Education (MSK CME) at least 7 days prior to the first day of the course ([email protected]).

Cancellations or no-shows after this date are not eligible for a refund. MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, we will refund the registration fee in full, but are not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies. At any time, you may substitute another registrant in your place after contacting MSK CME with the relevant information.

Please note if it has been more than 120 days since you paid for a course, or submitted a check for payment, a W9 form will need to be completed for us to refund your registration. You will not be taxed on your refund.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Memorial Sloan Kettering Cancer Center and the Asia-Pacific Primary Liver Cancer Expert Association (APPLE). Memorial Sloan Kettering Cancer Center is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 5.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Conference Chairs

Ghassan K. Abou-Alfa, MD
Attending 
Gastrointestinal Oncology Service
Department of Medicine 
Memorial Sloan Kettering Cancer Center 

Linda L. Wong, MD
Associate Member, Cancer Biology
University of Hawaii Cancer Center
Director, Liver Transplant Program
The Queen's Medical Center

Conference Faculty 

Faculty Disclosures (All Faculty)

Memorial Sloan Kettering gratefully acknowledges the following organizations for providing educational grants and financial support for this live activity:

AstraZeneca
Berry Oncology Co., LTD
Exelixis, Inc.
F Hoffmann-La Rochte Ltd
Sirtex Medical US Holdings, Inc.